ConductScience.org, home

Paper656120

Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.

Waldmeier PC and 1 other. Biochem Pharmacol, 1978. Cited by 50 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment. Papers, record 656120. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/656120

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment.
PubMed
Journal
Biochem Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.41
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waldmeier PCP C
2Felner AEA E

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Monoamine Oxidase InhibitorsMajor topic
PhenethylaminesMajor topic
Animals
Brain
Female
Harmaline
Rats
Serotonin
Time Factors

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
11,358,284Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.Neurochem Res2001https://conductscience.org/library/papers/11358284PubMed
10,484,286L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.Endocrine1999https://conductscience.org/library/papers/10484286PubMed
9,285,463Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease.J Neurol Neurosurg Psychiatry1997https://conductscience.org/library/papers/9285463PubMed
8,857,072Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.Eur J Clin Pharmacol1996https://conductscience.org/library/papers/8857072PubMed
3,929,314Tyramine pressor sensitivity changes during deprenyl treatment.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/3929314PubMed
745,017Recent observations on the clinical pharmacology of (-)deprenyl.J Neural Transm1978https://conductscience.org/library/papers/745017PubMed
745,013Absence of "cheese effect" during deprenyl therapy: some recent studies.J Neural Transm1978https://conductscience.org/library/papers/745013PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/656120

GET https://conductscience.org/api/papers/v1/656120/authors